Add BrightSurf on Google Email

Enzyme necessary for DNA synthesis can also erase DNA

Researchers at Uppsala University have identified a new enzyme necessary for DNA synthesis that can also erase DNA from bacterial chromosomes. By studying Salmonella mutants, they found that this enzyme plays a crucial role in spontaneous gene deletions, which can lead to the reduction of DNA content.

SourceUppsala University·JournalProceedings of the National Academy of Sciences·DateJun 8, 2009

DECIPHERing human disease

The DECIPHER database has revealed its developing role in revolutionizing both clinical practice and genetic research, providing a key to unlock the causes of illnesses. The data from around 100 centres has been shared openly worldwide, benefiting researchers, clinicians, and patients.

SourceWellcome Trust Sanger Institute·JournalAmerican Journal of Human Genetics·DateApr 15, 2009

Low levels of brain chemical may lead to obesity, NIH study of rare disorder shows

A National Institutes of Health study found that people with WAGR syndrome, a rare genetic condition, have low blood levels of the brain chemical BDNF and are more likely to become obese. The study suggests that BDNF plays a role in regulating appetite and body weight.

Aggressive therapy best for certain AML patients

A new study suggests that acute leukemia patients with a specific genetic mutation may benefit from aggressive therapy to extend their disease-free survival. Researchers found that treating patients with the MLL-PTD mutation with an autologous stem cell transplant significantly reduced early relapses.

SourceOhio State University·JournalBlood·DateAug 1, 2007

Chromosome glue repairs damaged DNA

Scientists at Karolinska Institutet have found a new way chromosomes are repaired after damage, contrary to the long-held view that cohesion only occurs during cell division. The discovery shows cohesin reactsivate when DNA breaks, allowing cells to fix damaged sister chromatids.

SourceKarolinska Institutet·JournalScience·DateJul 13, 2007

Mosquito genes explain response to climate change

Researchers have produced the first chromosomal map that shows regions of chromosomes that activate – and are apparently evolving – in animals in response to climate change. The map allows for identification of specific genes controlling seasonal development, which will help predict animal survival and disease-carrying vector movement.

SourceUniversity of Oregon·JournalGenetics·DateApr 23, 2007

Taking 'chips' to the next level of gene hunting

Researchers at Johns Hopkins Medicine have invented two new gene 'chip' technologies to identify disease-causing mutations in the human genome. The TIP-chip can locate transposable elements that disrupt normal gene function, while a second chip contains twice as much genetic information, enabling faster and cheaper experiments.

SourceJohns Hopkins Medicine·JournalProceedings of the National Academy of Sciences·DateNov 14, 2006

When Gleevec is not enough

Researchers discovered a new 'helper' compound, dasatinib, that effectively treats some leukemias by targeting both BCR-ABL and SRC kinases. The findings suggest addressing both pathways is crucial for optimal treatment outcomes.

SourceJackson Laboratory·JournalProceedings of the National Academy of Sciences·DateNov 7, 2006

Revelations of rice

The University of Arizona team successfully mapped and sequenced the rice genome, unlocking the secrets of over 37,500 genes. This breakthrough will enable researchers to identify desirable traits such as drought tolerance and pest resistance, leading to improved rice varieties for global food security.

SourceUniversity of Arizona·JournalNature·DateAug 10, 2005

Rewriting textbooks on DNA crossover

Scientists have made a groundbreaking discovery about DNA crossover during meiosis, which is crucial for sexual reproduction. The new findings suggest that the decision to make a crossover or non-crossover recombination is made much earlier than previously thought, shedding light on the molecular basis of this process.

New way to lock DNA-slicing enzyme onto chromosomes could lead to novel anti-cancer drugs

St. Jude scientists have discovered a new method to target the Topoisomerase 1 enzyme, crucial for cell division, leading to potential novel anti-cancer drugs that can work in combination with existing agents. This approach may also reduce cancer cells' ability to become resistant to treatment.

SourceSt. Jude Children's Research Hospital·JournalProceedings of the National Academy of Sciences·DateDec 12, 2003